IKBKB and neoplasm: Koliaraki have demonstrated that specific deletion of IKKβ in intestinal mesenchymal cells(IMCs) in vivo results in reduced tumor incidence following exposure to azoxymethane(AOM) and dextran sodium sulfate(DSS) treatment, which is associated with diminished inflammatory cell infiltration and tissue damage in the initial stages of disease development (73, 74).